Increasing evidence showed that KRAS mutations are closely associated with multiple cancers, including non-small-cell lung cancer, colorectal cancer, and pancreatic cancer, and NRAS mutations are present in melanomas [38]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.